RELMADA THERAPEUTICS, INC. Contractual Obligation, to be Paid, Year One
RELMADA THERAPEUTICS, INC. (RLMD) had Contractual Obligation, to be Paid, Year One of $90.35 thousand as of 2021-12-31, per its 10-K filed 2022-03-25.
Discontinued › Notes › Commitment and Contingencies › Contractual Obligation, Fiscal Year Maturity
us-gaap:ContractualObligationDueInNextTwelveMonths · last filed 2022-03-25
- 2021-12-31: Contractual Obligation, to be Paid, Year One $90.35K.
- 2021-09-30: Contractual Obligation, to be Paid, Year One $33.00K.
- 2021-06-30: Contractual Obligation, to be Paid, Year One $52.80K.
- 2021-03-31: Contractual Obligation, to be Paid, Year One $79.20K.
| Period end | Contractual Obligation, to be Paid, Year One | Contractual Obligation, to be Paid, Year One as first filed |
|---|---|---|
| 2021-12-31 | $90.35K 10-K · filed 2022-03-25 | |
| 2021-09-30 | $33.00K 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $52.80K 10-Q · filed 2021-08-10 | |
| 2021-03-31 | $79.20K 10-Q · filed 2021-05-12 | |
| 2020-09-30 | $41.40K 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $82.80K 10-Q · filed 2020-08-12 | |
| 2020-03-31 | $122.59K 10-Q · filed 2020-05-15 | |
| 2019-03-31 | $279.44K 10-Q · filed 2019-11-13 | $96.30K 10-Q · filed 2019-05-15 |
| 2018-12-31 | $204.90K 10-Q · filed 2019-02-13 | |
| 2018-09-30 | $4.72M 10-Q · filed 2018-11-13 | |
| 2018-03-31 | $65.70K 10-Q · filed 2018-05-14 | |
| 2017-12-31 | $176.25K 10-Q · filed 2018-02-12 | |
| 2017-09-30 | $227.34K 10-Q · filed 2017-11-14 | |
| 2017-03-31 | $372.02K 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $462.20K 10-Q · filed 2017-02-10 | |
| 2016-09-30 | $517.85K 10-Q · filed 2016-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |